Many studies of behavioral interventions have shown success in helping patients control their weight while also reducing obesity-related comorbidities.
As insurance companies struggle with how and whether to cover AOMs, it is important to consider how patients will adhere to taking them to ensure positive health outcomes.
Disrupted routines, school closures, increased stress, and less physical activity and proper nutrition all likely contributed to rises in childhood obesity rates during the pandemic.
Research presented at a recent Food and Drug Administration (FDA) workshop indicates the need for more comprehensive testing of new medications in people with obesity.